| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.86T | 2.89T | 2.80T | 2.51T | 2.18T |
| Gross Profit | 1.56T | 2.07T | 1.98T | 1.59T | 1.33T |
| EBITDA | 221.82B | 192.98B | 157.54B | -81.06B | 44.82B |
| Net Income | 138.97B | 126.41B | 98.78B | -132.15B | 14.18B |
Balance Sheet | |||||
| Total Assets | 17.32T | 16.62T | 17.21T | 16.77T | 17.81T |
| Cash, Cash Equivalents and Short-Term Investments | 1.92T | 778.68B | 1.14T | 1.14T | 890.67B |
| Total Debt | 231.98B | 186.34B | 21.52B | 184.82B | 231.28B |
| Total Liabilities | 15.70T | 15.31T | 15.80T | 15.78T | 16.42T |
| Stockholders Equity | 1.61T | 1.30T | 1.40T | 987.17B | 1.38T |
Cash Flow | |||||
| Free Cash Flow | 136.80B | -379.46B | 247.25B | -329.92B | -404.87B |
| Operating Cash Flow | 150.22B | -359.87B | 262.75B | -307.63B | -396.88B |
| Investing Cash Flow | -245.29B | 94.27B | -180.25B | 665.96B | 283.20B |
| Financing Cash Flow | -13.57B | -87.34B | -79.23B | -106.58B | -57.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.44T | 14.62 | 10.61% | 3.26% | 10.30% | 3.49% | |
74 Outperform | ¥54.03B | 8.21 | 6.16% | 1.10% | 4.70% | 44.87% | |
72 Outperform | ¥1.87T | 4.48 | 20.02% | 2.63% | 31.37% | 148.24% | |
71 Outperform | ¥131.20B | 16.31 | ― | ― | 14.78% | 34.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥2.26T | 16.81 | 7.91% | 2.74% | 6.17% | 16.15% | |
46 Neutral | ¥1.70T | 9.99 | ― | 2.44% | -12.57% | 42.29% |